T M Cox. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisGaucher Disease/drug therapyGaucher Disease/economicsGlucosylceramidase/economicsGlucosylceramidase/therapeutic useHumans
Substances: See more » algluceraseGlucosylceramidase
Year: 1995 PMID: 10155604 DOI: 10.2165/00019053-199508010-00009
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.981